Global $67B+ Womens Health Market Landscape 2024-2030: Analysis by Age, Application and Region
Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The "Global Womens Health Market Size, Share & Trends Analysis Report…
25,585€
0,08%
Echtzeit-Aktienkurs Myovant Sciences Ltd.
Bid:
Ask:
Nachrichten zur Myovant Sciences Ltd. Aktie
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Sumitovant Biopharma completes acquisition of Myovant Sciences
The deal was announced on 23 October 2022. Sumitovant has acquired all outstanding shares of Myovant it did not own…
Insiderhandel: Insider kauft Aktien von Myovant Sciences im Wert von 1.393.178.400$
Sumitomo Chemical Co., Ltd. - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2023-03-10...…
Form 8-K Myovant Sciences Ltd. For: Mar 10
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sumitovant Biopharma Completes Acquisition of Myovant Sciences
NEW YORK and BASEL, Switzerland, March 10, 2023 /PRNewswire/ -- Sumitovant Biopharma Ltd. ("Sumitovant") and Myovant Sciences Ltd. ("Myovant") announced…
XFRA : Deletion of Instruments from Boerse Frankfurt - 09.03.2023
The following instruments on Boerse Frankfurt do have their last trading day on 09.03.2023
Die folgenden Instrumente in Boerse Frankfurt haben…
Form 8-K Myovant Sciences Ltd. For: Mar 01
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Myovant Sciences (MYOV) Reports Q3 Loss, Lags Revenue Estimates
Myovant Sciences (MYOV) delivered earnings and revenue surprises of -5.36% and 3.44%, respectively, for the quarter ended December 2022. Do…
Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022
BASEL, Switzerland, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a biopharmaceutical company that aspires to redefine…
Form 10-Q Myovant Sciences Ltd. For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Myovant Sciences Ltd. For: Jan 26
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: Chief Commercial Officer verkauft Aktien von Myovant Sciences im Wert von 53.995$
Merendino, Lauren - Vorstand - Tag der Transaktion: 2023-01-18...…
Insiderhandel: Chief Medical Officer verkauft Aktien von Myovant Sciences im Wert von 29.821$
Ferreira, Juan Camilo Arjona - Vorstand - Tag der Transaktion: 2023-01-18...…
Insiderhandel: General Counsel & Corp. Secy. verkauft Aktien von Myovant Sciences im Wert von 34.204$
Lang, Matthew - Vorstand - Tag der Transaktion: 2023-01-18...…
Insiderhandel: Principal Executive Officer verkauft Aktien von Myovant Sciences im Wert von 216.115$
Marek, David C. - Vorstand - Tag der Transaktion: 2023-01-18...…
MYOVANT SCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV
NEW ORLEANS, Jan. 11, 2023 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law…
Insiderhandel: Principal Financial Officer verkauft Aktien von Myovant Sciences im Wert von 59.947$
Mehra, Uneek - Vorstand - Tag der Transaktion: 2022-12-16...…
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
BASEL, Switzerland, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a biopharmaceutical company that aspires to redefine care…
Myovant Sciences Appoints Ann Tomlin as Senior Vice President of Human Resources
BASEL, Switzerland, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) today announced the appointment of Ann…
Myovant Sciences: Q2 Earnings Insights
Myovant Sciences (NYSE:MYOV) reported its Q2 earnings results on Wednesday, October 26, 2022 at 08:30 AM.
Here's what investors need to…
Myovant Sciences GAAP EPS of -$0.47 beats by $0.02, revenue of $104.8M beats by $11.33M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Myovant Sciences Announces Corporate Updates and Financial Results for Second Fiscal Quarter 2022
BASEL, Switzerland, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a biopharmaceutical company that aspires to redefine…
Form 8-K Myovant Sciences Ltd. For: Oct 26
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Myovant Sciences downgraded to hold from outperform at Evercore ISI
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Myovant Sciences Ltd. - MYOV
NEW YORK, Oct. 24, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde &…
Myovant Sciences Accepts Slightly Higher Takeover Offer
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
SHAREHOLDER ALERT: Weiss Law Investigates Myovant Sciences Ltd.
NEW YORK, Oct. 24, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of…
Myovant Sciences Cancels Second Quarter Earnings Conference Call
BASEL, Switzerland, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) (“Myovant”) today announced the cancellation of…
Vaxcyte, Myovant rise; Dorman, Shift4 Payments fall
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:...…
Myovant Sciences Accepts Sweetened $2.9 Billion Bid From Sumitomo Pharma
Myovant develops drugs to treat infertility in women and prostate cancer in men. The stock took off....…
Thinking about buying stock in Myovant Sciences, Sellas Life Sciences, Borr Drilling, Mullen Automotive, or Immunic?
NEW YORK, Oct. 24, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MYOV, SLS, BORR, MULN, and IMUX. To…
Myovant Sciences shares trading higher after agreeing to Sumitomo deal for $2.9 billion
Shares of Myovant Sciences Ltd. were up 8.2% in premarket trading on Monday, the day after the company said…
Myovant stock pops as Sumitovant to acquire remaining stake for $1.7B
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Myovant Sciences Ltd. For: Oct 23
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Myovant Sciences Shares Rise Premarket on Sumitomo Takeover >MYOV
Myovant Sciences Shares Rise Premarket on Sumitomo Takeover >MYOV...…
Myovant Sciences: NBC-Titel verabschiedet sich via Übernahme!
Die von uns antizipierte Übernahmewelle hält an und „trifft“ nun auch endlich die lange erwartete Übernahme aus dem Reigen der…
Myovant Sciences, Discover Financial And 3 Stocks To Watch Heading Into Monday
With US stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today…
Myovant Agrees To Be Acquired By Sumitomo Pharma Unit In $1.7B Deal As Japanese Company Sweetens Bid
Myovant Sciences, Inc. (NYSE: MYOV) announced late Sunday a deal to be acquired by Japanese pharmaceutical company Sumitomo Pharma Co.,…
UPDATE 1-Sumitovant Biopharma to buy Myovant for $27 per share
...(Adds details)
Oct 23 (Reuters) - Sumitovant Biopharma Ltd, along......…
Sumitovant Biopharma to buy Myovant for $27 per share
...Oct 23 (Reuters) - Sumitovant Biopharma Ltd, along with
parent......…
Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement
Sumitovant Biopharma to Acquire all Outstanding Shares of Myovant for $27 Per Share in Cash...…
Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement
Sumitovant Biopharma to Acquire all Outstanding Shares of Myovant for $27 Per Share in Cash Combination Provides Expertise and Resources…
Form 8-K Myovant Sciences Ltd. For: Oct 21
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: Chief Medical Officer verkauft Aktien von Myovant Sciences im Wert von 40.421$
Ferreira, Juan Camilo Arjona - Vorstand - Tag der Transaktion: 2022-10-18...…